Masataka Igeta

526 total citations
35 papers, 164 citations indexed

About

Masataka Igeta is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Masataka Igeta has authored 35 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 7 papers in Oncology. Recurrent topics in Masataka Igeta's work include Statistical Methods in Clinical Trials (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Masataka Igeta is often cited by papers focused on Statistical Methods in Clinical Trials (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Masataka Igeta collaborates with scholars based in Japan and China. Masataka Igeta's co-authors include Koichiro Yamakado, Kazuomi Kario, Kazuaki Enya, Hiromi Rakugi, Takashi Ohira, Masataka Ikeda, Kohei Kaku, Yasunori Kurahashi, Shigeyuki Matsui and M. Tanooka and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biometrics.

In The Last Decade

Masataka Igeta

28 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masataka Igeta Japan	9	53	52	37	35	31	35	164
S. Wood United Kingdom	7	62 1.2×	65 1.3×	32 0.9×	34 1.0×	46 1.5×	10	215
Peter-Paul Willemse Netherlands	7	73 1.4×	175 3.4×	34 0.9×	32 0.9×	16 0.5×	21	262
Konstantinos Bouchagier Greece	7	89 1.7×	43 0.8×	60 1.6×	20 0.6×	23 0.7×	21	190
Mina Youssef Egypt	9	64 1.2×	44 0.8×	24 0.6×	34 1.0×	9 0.3×	31	209
Yin Liu China	8	31 0.6×	34 0.7×	57 1.5×	33 0.9×	57 1.8×	32	185
Roger Huang New Zealand	5	50 0.9×	30 0.6×	12 0.3×	23 0.7×	17 0.5×	7	120
Bao‐Ngoc Nguyen United States	9	63 1.2×	93 1.8×	35 0.9×	44 1.3×	75 2.4×	41	223
Mohamed Sami Mourali Tunisia	7	30 0.6×	29 0.6×	19 0.5×	27 0.8×	76 2.5×	48	175
Nicholas Fung Hong Kong	8	49 0.9×	51 1.0×	46 1.2×	35 1.0×	11 0.4×	16	264

Countries citing papers authored by Masataka Igeta

Since Specialization

Citations

This map shows the geographic impact of Masataka Igeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Igeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Igeta more than expected).

Fields of papers citing papers by Masataka Igeta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Igeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Igeta. The network helps show where Masataka Igeta may publish in the future.

Co-authorship network of co-authors of Masataka Igeta

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Igeta. A scholar is included among the top collaborators of Masataka Igeta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Igeta. Masataka Igeta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Igeta, Masataka, Takashi Morimoto, Masayuki Nagahashi, et al.. (2025). Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters. Breast Cancer. 32(3). 500–511. 2 indexed citations

Takagi, Yasuhiro, Toshiyuki Sato, Masataka Igeta, et al.. (2025). Real‐World Effectiveness and Safety of Mirikizumab Induction Therapy in Patients With Ulcerative Colitis: A Multicentre Retrospective Observational Study. Alimentary Pharmacology & Therapeutics. 61(12). 1923–1934. 4 indexed citations

Honda, Yosuke, et al.. (2025). Pre‐stroke patient characteristics that influence skeletal muscle quality: A cross‐sectional study. Geriatrics and gerontology international. 25(2). 213–219.

Igeta, Masataka, et al.. (2025). Effectiveness of artificial intelligence–based visualization for surgical anatomy education: A cluster quasirandomized controlled trial. Surgery. 188. 109723–109723.

Igeta, Masataka, et al.. (2025). Efficacy of robot-assisted double-flap techniques with refinements to minimize anastomosis-related complications after proximal gastrectomy. Surgery Today. 55(7). 977–985.

Uchino, Motoi, et al.. (2024). The Comprehensive Complication Index in Ulcerative Colitis: A Comparison with the Clavien‒Dindo Classification. Inflammatory Intestinal Diseases. 9(1). 85–95. 1 indexed citations

Uchino, Motoi, Masataka Igeta, Kozo Kataoka, et al.. (2023). Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer. International Journal of Colorectal Disease. 38(1). 113–113. 1 indexed citations

Miyoshi, Akio, M Kadoya, Masataka Igeta, et al.. (2023). RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation. Brain Behavior and Immunity. 116. 329–348. 13 indexed citations

Fujiwara, Masayuki, et al.. (2023). Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB–VMAT. Anticancer Research. 44(1). 323–329. 1 indexed citations

10.

Maeda, Shusaku, Köichi Toda, Kazuo Shimamura, et al.. (2023). Preoperative higher right ventricular stroke work index increases the risk of de novo aortic insufficiency after continuous-flow left ventricular assist device implantation. Journal of Artificial Organs. 27(3). 222–229.

11.

Kuribayashi, Kozo, Masataka Igeta, Takashi Daimon, et al.. (2022). Clinical Efficacy and Safety of Ni<underline>v</underline>olumab in Mal<underline>i</underline>gnant N<underline>o</underline>n-Pleural Mesothe<underline>l</underline>iom<underline>a</underline>: A Multicenter, Open-Label, Single-Arm, Japanese Phase II Trial (VIOLA) Protocol. Oncology. 101(4). 257–261. 2 indexed citations

12.

Kitajima, Kazuhiro, Masataka Igeta, Junpei Kuyama, et al.. (2022). Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial. European Journal of Nuclear Medicine and Molecular Imaging. 50(5). 1487–1498. 11 indexed citations

13.

Maeda, Shusaku, Köichi Toda, Kazuo Shimamura, et al.. (2022). Long-term survival after surgical or transcatheter aortic valve replacement for low or intermediate surgical risk aortic stenosis: Comparison with general population. Journal of Cardiology. 81(1). 68–75. 4 indexed citations

14.

Ishihara, Masaharu, Masanori Asakura, Kiyoshi Hibi, et al.. (2022). Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial. EuroIntervention. 18(8). e647–e655. 13 indexed citations

15.

Ishida, Yoshinori, et al.. (2021). Potential advantages of robotic total gastrectomy for gastric cancer: a retrospective comparative cohort study. Journal of Robotic Surgery. 16(4). 959–966. 7 indexed citations

16.

Asakura, Masanori, Kiyoshi Hibi, Wataru Shimizu, et al.. (2021). Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease. Journal of Cardiology. 79(1). 105–109. 2 indexed citations

17.

Takaki, Haruyuki, Masataka Igeta, Masayuki Fujiwara, et al.. (2021). Development and Accuracy Evaluation of Augmented Reality-based Patient Positioning System in Radiotherapy: A Phantom Study. In Vivo. 35(4). 2081–2087. 13 indexed citations

18.

Fujiwara, Masayuki, Hiroshi Doi, Masataka Igeta, et al.. (2021). Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer. Anticancer Research. 41(11). 5793–5802. 13 indexed citations

19.

Kaku, Kohei, et al.. (2015). Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double‐blind, parallel‐group, comparative study. Diabetes Obesity and Metabolism. 17(12). 1198–1201. 10 indexed citations

20.

Rakugi, Hiromi, et al.. (2013). Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension. Blood Pressure. 22(sup1). 22–28. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact